{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T01:13:17Z","timestamp":1790039597387,"version":"4.0.1"},"reference-count":12,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003569","name":"Korean Ministry of Food and Drug Safety","doi-asserted-by":"crossref","award":["17161MFDS062"],"award-info":[{"award-number":["17161MFDS062"]}],"id":[{"id":"10.13039\/501100003569","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Forensic Science International"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.forsciint.2018.03.021","type":"journal-article","created":{"date-parts":[[2018,3,18]],"date-time":"2018-03-18T14:00:59Z","timestamp":1521381659000},"page":"199-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Isolation and structural characterization of a novel sibutramine analogue, chlorosipentramine, in a slimming dietary supplement, by using HPLC-PDA, LC\u2013Q-TOF\/MS, FT-IR, and NMR"],"prefix":"10.1016","volume":"286","author":[{"given":"Jisuk","family":"Yun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kye Jung","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jangduck","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0663-1669","authenticated-orcid":false,"given":"Cheon-Ho","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.forsciint.2018.03.021_bib0005","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1046\/j.1467-789x.2000.00020.x","article-title":"An assessment of the safety and efficacy of sibutramine, an anti-obesity drug with a novel mechanism of action","volume":"1","author":"Nisoli","year":"2000","journal-title":"Obes. Rev."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0010","unstructured":"FDA (Food and Drug Administration), Memorandum to the File NDA 20-632 Meridia (sibutramine hydrochloride monohydrate). October 4, 2010. http:\/\/www.fda.gov\/downloads\/Drugs\/DrugSafety\/UCM228795.pdf. (Accessed 18 July 2017)."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0015","unstructured":"EMA (European Medicines Agency), European Medicines Agency recommends suspension of marketing authorisations for sibutramine. Press release. EMA\/39408\/2010. London (UK), 2010."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0020","first-page":"396","article-title":"Detection of synthetic anti-obesity drugs, designer analogues and weight-loss ingredients as adulterants in slimming foodsfrom 2015 to 2017","volume":"9","author":"Yun","year":"2018","journal-title":"J. Chromatogr. Sep. Tech."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0025","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1255\/ejms.797","article-title":"Determination of N-desmethyl- and N-bisdesmethyl metabolites of sibutramine in doping control analysis using liquid chromatography\u2013tandem mass spectrometry","volume":"12","author":"Thevis","year":"2006","journal-title":"Eur. J. Mass Spctrom."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0030","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/chromsci\/46.8.707","article-title":"Simultaneous determination of sibutramine and N-di-desmethylsibutramine in dietary supplements for weight control by HPLC\u2013ESI-MS","volume":"46","author":"Huang","year":"2008","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0035","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1002\/rcm.2876","article-title":"Detection of sibutramine, its two metabolites and one analogue in a herbal product for weight loss by liquid chromatography triple quadrupole mass spectrometry and time-of-flight mass spectrometry","volume":"21","author":"Zou","year":"2007","journal-title":"Rapid Commun. Mass Spectrom."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0040","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jpba.2013.02.031","article-title":"Rapid screening and structural elucidation of a novel sibutramine analogue in a weight loss supplement: 11-desisobutyl-11-benzylsibutramine","volume":"83","author":"Mans","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0045","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1080\/19440049.2013.793826","article-title":"Isolation and identification of a sibutramine analogue adulterated in slimming dietary supplements","volume":"30","author":"Kim","year":"2013","journal-title":"Food Addit. Contram. Part A"},{"key":"10.1016\/j.forsciint.2018.03.021_bib0050","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jpba.2013.08.031","article-title":"Screening for multiple weight loss and related drugs in dietary supplement materials by flow injection tandem mass spectrometry and their confirmation by liquid chromatography tandem mass spectrometry","volume":"88","author":"Song","year":"2014","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0055","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/dom.12657","article-title":"Evolution of pharmacological obesity treatments: focus on adverse side-effect profiles","volume":"18","author":"Krentz","year":"2016","journal-title":"Diabetes Obes. Metab."},{"key":"10.1016\/j.forsciint.2018.03.021_bib0060","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1002\/dmrr.2349","article-title":"Do we need anti-obesity drugs?","volume":"28","author":"Hainer","year":"2012","journal-title":"Diabetes Metab. Res. Rev."}],"container-title":["Forensic Science International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381830118X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S037907381830118X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T12:55:38Z","timestamp":1549284938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S037907381830118X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":12,"alternative-id":["S037907381830118X"],"URL":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.03.021","relation":{},"ISSN":["0379-0738"],"issn-type":[{"value":"0379-0738","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isolation and structural characterization of a novel sibutramine analogue, chlorosipentramine, in a slimming dietary supplement, by using HPLC-PDA, LC\u2013Q-TOF\/MS, FT-IR, and NMR","name":"articletitle","label":"Article Title"},{"value":"Forensic Science International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.forsciint.2018.03.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}